6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one

C88H88F2N26O4 — CID 163914522

IUPAC6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one
SMILESCC(F)Cn1ccc(-c2nc3n(c2-c2ccc4ncn(C)c(=O)c4c2)CCC3)n1.CC(F)Cn1ccc(-c2nc3n(c2-c2ccc4ncn(CCN5CCOCC5)c(=O)c4c2)CCC3)n1.NC(=O)c1cnc2ccc(-c3c(-c4ccn(C5CC5)n4)nc4n3CCC4)cc2n1.c1cnc2cc(-c3c(-c4ccn(C5CC5)n4)nc4n3CCC4)ccc2n1
InChIInChI=1S/C26H30FN7O2.C21H21FN6O.C21H19N7O.C20H18N6/c1-18(27)16-33-8-6-22(30-33)24-25(34-7-2-3-23(34)29-24)19-4-5-21-20(15-19)26(35)32(17-28-21)10-9-31-11-13-36-14-12-31;1-13(22)11-27-9-7-17(25-27)19-20(28-8-3-4-18(28)24-19)14-5-6-16-15(10-14)21(29)26(2)12-23-16;22-21(29)17-11-23-14-6-3-12(10-16(14)24-17)20-19(25-18-2-1-8-27(18)20)15-7-9-28(26-15)13-4-5-13;1-2-18-23-19(16-7-11-26(24-16)14-4-5-14)20(25(18)10-1)13-3-6-15-17(12-13)22-9-8-21-15/h4-6,8,15,17-18H,2-3,7,9-14,16H2,1H3;5-7,9-10,12-13H,3-4,8,11H2,1-2H3;3,6-7,9-11,13H,1-2,4-5,8H2,(H2,22,29);3,6-9,11-12,14H,1-2,4-5,10H2
InChIKeyQVBMJLANWODGPR-UHFFFAOYSA-N
MW1611.85 g/mol
LogP12.10
Rot. Bonds18

About 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one

6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one (PubChem CID 163914522) has the molecular formula C88H88F2N26O4 and a molecular weight of 1611.85 g/mol. Its IUPAC name is 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one.

Molecular Properties

Compound Name6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one
PubChem CID163914522
Molecular FormulaC88H88F2N26O4
Molecular Weight1611.85 g/mol
Exact Mass1610.74
IUPAC Name6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one
SMILESCC(F)Cn1ccc(-c2nc3n(c2-c2ccc4ncn(C)c(=O)c4c2)CCC3)n1.CC(F)Cn1ccc(-c2nc3n(c2-c2ccc4ncn(CCN5CCOCC5)c(=O)c4c2)CCC3)n1.NC(=O)c1cnc2ccc(-c3c(-c4ccn(C5CC5)n4)nc4n3CCC4)cc2n1.c1cnc2cc(-c3c(-c4ccn(C5CC5)n4)nc4n3CCC4)ccc2n1
InChIInChI=1S/C26H30FN7O2.C21H21FN6O.C21H19N7O.C20H18N6/c1-18(27)16-33-8-6-22(30-33)24-25(34-7-2-3-23(34)29-24)19-4-5-21-20(15-19)26(35)32(17-28-21)10-9-31-11-13-36-14-12-31;1-13(22)11-27-9-7-17(25-27)19-20(28-8-3-4-18(28)24-19)14-5-6-16-15(10-14)21(29)26(2)12-23-16;22-21(29)17-11-23-14-6-3-12(10-16(14)24-17)20-19(25-18-2-1-8-27(18)20)15-7-9-28(26-15)13-4-5-13;1-2-18-23-19(16-7-11-26(24-16)14-4-5-14)20(25(18)10-1)13-3-6-15-17(12-13)22-9-8-21-15/h4-6,8,15,17-18H,2-3,7,9-14,16H2,1H3;5-7,9-10,12-13H,3-4,8,11H2,1-2H3;3,6-7,9-11,13H,1-2,4-5,8H2,(H2,22,29);3,6-9,11-12,14H,1-2,4-5,10H2
InChIKeyQVBMJLANWODGPR-UHFFFAOYSA-N
XLogP12.10
TPSA319.46 Ų
H-Bond Donors1
H-Bond Acceptors29
Rotatable Bonds18
Heavy Atoms120
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001611.85
LogP ≤ 512.10
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1029

Analyze 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one?
The IUPAC name of 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one (CID 163914522) is 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one.
What is the SMILES notation for 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one?
The canonical SMILES for 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one is CC(F)Cn1ccc(-c2nc3n(c2-c2ccc4ncn(C)c(=O)c4c2)CCC3)n1.CC(F)Cn1ccc(-c2nc3n(c2-c2ccc4ncn(CCN5CCOCC5)c(=O)c4c2)CCC3)n1.NC(=O)c1cnc2ccc(-c3c(-c4ccn(C5CC5)n4)nc4n3CCC4)cc2n1.c1cnc2cc(-c3c(-c4ccn(C5CC5)n4)nc4n3CCC4)ccc2n1.
What is the InChIKey of 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one?
The InChIKey is QVBMJLANWODGPR-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30FN7O2.C21H21FN6O.C21H19N7O.C20H18N6/c1-18(27)16-33-8-6-22(30-33)24-25(34-7-2-3-23(34)29-24)19-4-5-21-20(15-19)26(35)32(17-28-21)10-9-31-11-13-36-14-12-31;1-13(22)11-27-9-7-17(25-27)19-20(28-8-3-4-18(28)24-19)14-5-6-16-15(10-14)21(29)26(2)12-23-16;22-21(29)17-11-23-14-6-3-12(10-16(14)24-17)20-19(25-18-2-1-8-27(18)20)15-7-9-28(26-15)13-4-5-13;1-2-18-23-19(16-7-11-26(24-16)14-4-5-14)20(25(18)10-1)13-3-6-15-17(12-13)22-9-8-21-15/h4-6,8,15,17-18H,2-3,7,9-14,16H2,1H3;5-7,9-10,12-13H,3-4,8,11H2,1-2H3;3,6-7,9-11,13H,1-2,4-5,8H2,(H2,22,29);3,6-9,11-12,14H,1-2,4-5,10H2.
What are the key properties of 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one?
6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one has a molecular weight of 1611.85 g/mol, XLogP of 12.10, 18 rotatable bonds, 1 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline;7-[2-(1-cyclopropylpyrazol-3-yl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]quinoxaline-2-carboxamide;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-methylquinazolin-4-one;6-[2-[1-(2-fluoropropyl)pyrazol-3-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-3-(2-morpholin-4-ylethyl)quinazolin-4-one is sourced from PubChem (CID 163914522), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).